INTRODUCTION
It is postulated that pathological changes in vessel structure seen in conditions such as hypertensive arteriopathy, atherosclerosis and restenosis are induced in part by signaling pathways that govern cell growth, death, differentiation and matrix production (1, 2) . However, the factors that regulate these programs within the vasculature remain poorly defined.
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephelopathy) is a heritable syndrome characterized by a predisposition to stroke due to an underlying arteriopathy. This diffuse arteriopathy is characterized by prominent degeneration and eventual loss of VSMC from the vessel wall (3, 4) . Genetic linkage analyses have documented mutations in Notch3 as the etiologic basis of the CADASIL syndrome (3-7).
Furthermore, Notch3 expression is largely confined to VSMC in adulthood (3) . These findings suggest that the Notch pathway may be an important determinant of VSMC fate and vascular structure in human health and disease.
The Notch family of receptors has been characterized as critical determinants of cell fate in a variety of organisms. In mice, Notch-1 and Notch-2 gene deletions are characterized by perturbations in organogenesis that result in embryonic lethality (8, 9) . Mechanistic studies performed in cell culture models in other cell types indicate that the Notch pathway influences cell fate by regulating programs governing growth, apoptosis and differentiation (10) (11) (12) (13) (14) .
However, the functional role of the Notch signaling pathway in VSMC in vitro and in vivo remains to be defined.
Notch3 Signaling Promotes Vascular Smooth Muscle Cell Survival
The Notch receptor family is activated via a proteolytic cleavage of the intracellular domain (IC) of Notch. In certain contexts, the Notch IC portion translocates to the nucleus (15) (16) (17) .
In the classic model, in response to Notch signaling, RBP-Jk activates transcription of basic helix-loop-helix (bHLH) transcription factors such as hairy-and-enhancer of split 1 (HES-1) (18) and the Hairy-related transcription-factor (HRT) genes (19) .
Zebrafish embryos harboring a mutation in Gridlock, an orthologue of HRT2, show dramatic impairment of vascular formation (20) . Furthermore, recent evidence has established that Gridlock expression is a critical determinant of arterial versus venous cell fate within the developing vasculature (21, 22) .
In addition to the classical model of Notch signaling via RBP-Jk-dependent transcriptional events, Notch may engage other signaling cascades in a cross-talk fashion.
Recent studies indicate that in certain contexts, the Notch signaling pathway may modulate Src and Ras signal transduction (23) (24) (25) . However, the elucidation of Notch3 signaling via RBP-Jkdependent versus signal transduction cross talk and the activation of downstream target genes in adult VSMC remains to be defined.
Studies from our and several other laboratories have suggested that apoptosis may play an essential role in atherogenesis and vascular remodeling (26-28). VSMC apoptosis is a prominent (32) . c-FLIP is up-regulated in the intima and media after arterial injury and remodeling (33) . Furthermore, there are additional reports suggesting that the extracellular signal-regulated kinase (ERK) cascade functions as a survival pathway by regulating c-FLIP expression (34) (35) (36) ).
The present study tested the hypothesis that Notch3 signaling is a critical determinant of VSMC survival. We employed both in vitro and in vivo model systems to investigate the relationship between the Notch3 signaling pathway and the inhibition of FasL-induced apoptosis in VSMC and define down-stream mediators responsible for the survival-promoting function. In accord with this hypothesis, our findings indicate that Notch3 signaling inhibits Fas L-induced cell death through the up-regulation of c-FLIP via an ERK/MAPK-dependent pathway, suggesting a mechanism through which Notch3 in a cross-talk fashion governs VSMC fate and ultimately vascular structure. Determination of apoptosis: Quantitative nuclear chromatin morphology was employed for the apoptosis counting. Cells to be analyzed for apoptosis by nuclear chromatin morphology are stained with Hoechst 33342 (H33342) and assessed for the characteristic condensed, coalesced chromatin pattern of apoptotic cells as previously described by our laboratory (27, 28, 37) . For Fas ligand-induced apoptosis, 70% confluent cells in 2% FBS were treated with 25 ng/ml Fas ligand (Upstate Biotechnology, Lake Placid, NY) vs vehicle control for 24 hours prior to harvest and determination of percent apoptotic nuclei as described above.

MATERIALS AND METHODS
Cell
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Plasmid preparation and cloning: N3IC and HRT1 were released from their expression vectors 
Statistical analysis: All experiments, including the immunoblots, were independently repeated at least three times. Comparisons between two groups were analyzed via a student's T-test, and values of P < 0.05 were considered to be significant. Results were presented as means ± SEM. At least 3 different samples were analyzed in each experimental group.
RESULTS
Notch3 signaling promotes VSMC survival
To define the functional role of Notch3 signaling in VSMC, we initially established an in vitro model system. We generated a VSMC stable cell line expressing the constitutively active intracellular portion of Notch3 (N3IC) by retroviral transfection and marker selection. The selected cell line, N3ICSMC, exhibited a 35-fold up-regulation of Notch3 mRNA compared with its control cell line (Fig 1, left) , and a correspondingly dramatic increase in Notch3 IC protein (Fig 1, right) . In addition, we confirmed that N3ICSMC exhibited significant tonic up-regulation of the HRT1 and 2 genes, previously described as down-stream target genes of Notch signaling in other cell types (data not shown). To determine the functional role of Notch3 signaling on VSMC fate, we investigated the effect of Notch3 on promoting VSMC survival. We defined the anti-apoptotic effect of Notch3 signaling in N3ICSMC by quantitative nuclear chromatin morphology analysis as previously described by our laboratory (27, 28, 37 
Notch3 signaling induces c-FLIP expression in VSMC
To define the potential mechanism by which Notch3 signaling confers resistance to FasLinduced apoptosis, we investigated the expression levels of several putative mediators of apoptosis and FasL signaling in VSMC. In the N3ICSMC cells, we examined the mRNA and protein expression levels of c-FLIP, IAP and Bcl-2 compared to the control cell line. We established that resistance to FasL-induced apoptosis was associated with the induction of c-FLIP, a primary inhibitor of the Fas signaling pathway, as quantitated by real time RT-PCR and immunoblotting (Fig 3) . As depicted in Figure 3 , steady state mRNA levels of c-FLIP were upregulated about 2-fold in N3ICSMC versus the control cell line. Accordingly, the Notch3-induced up-regulation of c-FLIP was defined by a corresponding increase in protein expression confirmed by immunoblotting ( Figure 3 , right panel).
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Notch3 induces c-FLIP expression through an RBP-Jk-independent mechanism
After establishing that Notch3 signaling induced c-FLIP expression in association with promoting VSMC survival, it remained to be determined whether c 
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Notch 3 and c-FLIP are coordinately regulated in response to arterial injury
After defining that Notch3 signaling promotes VSMC survival through the up-regulation c-FLIP in vitro, we further postulated that the well-described modulation of VSMC fate in vascular lesion formation involves a coordinate regulation of Notch3 and c-FLIP. To test this postulate, we examined the coordinate expression levels of Notch3 and c-FLIP in rat carotid arteries following standard balloon injury. As depicted in Figure 7A , as we have previously reported (38) , Notch3 is acutely down-regulated within one week post-injury, exhibiting approximately a 6-fold change in mRNA expression levels at day 5. This down-regulation is seen at both the mRNA and protein level by QRTPCR and immunoblotting, respectively. When we examined the expression levels of c-FLIP at the same time point, we observed a similar, coordinate down-regulation of mRNA and protein by QRTPCR and immunoblotting, respectively ( Figure 7B ). Similar findings with Notch3 and c-FLIP were observed at day 3 postinjury. By day 7, the expression levels of both Notch3 and c-FLIP genes returned to pre-injury levels (data not shown).
We further postulated that an up-regulation of Notch3 expression is a characteristic of the altered growth and apoptosis phenotype associated with neointimal cells. Previous reports indicate that c-FLIP expression is elevated within intimal cells of remodeled arteries(26).
Accordingly, as indicated in Figure 8A , c-FLIP mRNA and protein levels were increased within tissue selectively isolated from the intima of carotid arteries 4 weeks after carotid balloon injury compared to the paired contralateral uninjured vessel. When we examined Notch3 mRNA and protein levels within the same neointimal tissue, we observed significantly elevated expression levels coordinate with increased c-FLIP expression ( Figure 8B ). Taken together, these findings Intriguingly, it is reported that c-FLIP is expressed in the neointima in animal models and in human atherosclerosis (32, 33) . In accord with these previous descriptions, the present study mRNA levels were determined by QRTPCR and normalized to GAPDH. n=5; *p<0.01.
Immunoblot analysis is representative of 4 matched vessel pairs. 
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